SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, ...

The Company also announced that its management team plans to present and meet with investors at the following upcoming investor conferences: ...

Additional information about the reverse stock split can be found in the definitive proxy statement filed with the Securities and Exchange Commission (SEC) on June 10, 2025, which is available on the ...

In addition, Fractyl granted the underwriters a 30-day option to purchase up to an additional 2,857,142 shares of common stock, along with associated Tranche A and Tranche B Warrants, at the public ...

Francisco Javier Duran, Chief Executive Officer of Durgalab, added, “We are confident in bringing FemBloc to Spain, supported by its positive safety profile and compelling value proposition. FemBloc ...

Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an ...

– Company to Host Conference Call on August 13, 2025, at 4:30 p.m. ET – ...

FDA response expected within six weeks; Company remains focused on 2025 U.S. expansion. NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ( ...

RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers approved to purchase RenovoCath. Four active cancer cent ...

TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- As Ontario commits $1.8 billion to expand access to team-based primary care, the Lung Health Foundation (LHF) is calling on the government to take a vital ...

ROSELAND. N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, ...

A live webcast and subsequent archived replay of the presentation may be accessed via the Investors section of the Company website at www.eyepointpharma.com. The replay will be available for 90 days ...